Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
378K
-
Shares change
-
+87.4K
-
Total reported value, excl. options
-
$3.4M
-
Value change
-
+$790K
-
Number of buys
-
13
-
Number of sells
-
-4
-
Price
-
$9.00
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q4 2017
28 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q4 2017.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 378K shares
of 41M outstanding shares and own 0.92% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (93.5K shares), BARCLAYS PLC (41.2K shares), MORGAN STANLEY (36K shares), DEUTSCHE BANK AG\ (34.6K shares), PNC FINANCIAL SERVICES GROUP, INC. (21.2K shares), GLENMEDE TRUST CO NA (20K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (18.5K shares), UBS Group AG (17.4K shares), MILLENNIUM MANAGEMENT LLC (15.8K shares), and Rossmore Private Capital (15.1K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.